Skip to content
Archive

Kolinpharma in Il Sole 24 Ore’s “Leader della crescita 2026” ranking

Kolinpharma S.p.A. is driven by an entrepreneurial spirit and a mindset constantly focused on improvement.

The company ranked 343rd out of 500 in the "Leader della crescita 2026" (Growth Leaders 2026) ranking, the annual listing that recognises the Italian companies with the highest revenue growth.

The official ranking was published online by Il Sole 24 Ore, a sign of the solidity and dynamism of our growth path. An extraordinary result that rewards the commitment of the whole team!

You can find the official ranking here: 2026 Ranking

More news

  1. "Europe’s Long-term Growth Champions” 2026: Kolinpharma® si classifica al primo posto tra le aziende europee del settore Health Care & Life Sciences nel ranking stilato da Financial Times e da Statista
  2. KOLINPHARMA premiata con il riconoscimento “Impresa e Valore”
  3. Dalla confusione alla chiarezza: perché l'Italia deve dettare linee guida specifiche per i nutraceutici. La proposta di Kolinpharma®.
Archive